Brief: Faes Farma Sees 2026 EBITDA Growth Between 28% And 31%
Feb 26 (Reuters) - Faes Farma SA FAE.MC: FAES FARMA SEES 2026 REVENUES +17%/+19% FAES FARMA SEES 2026 EBITDA +28% / +31% Source text: ID:nCNM6j7F75 Further company coverage: FAE.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))